BlackRock’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | -$1 | – | 5294 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5276 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5280 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5373 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5444 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5498 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5559 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5761 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5901 |
|
|
2022
Q2 | – | Sell |
-323
| Closed | -$30.4K | – | 5952 |
|
|
2022
Q1 | $31K | Sell |
323
-15
| -4% | -$1.43K | ﹤0.01% | 5501 |
|
|
2021
Q4 | $37K | Buy |
338
+8
| +2% | +$1.27K | ﹤0.01% | 5458 |
|
|
2021
Q3 | $72K | Sell |
330
-71
| -18% | -$14.8K | ﹤0.01% | 5221 |
|
|
2021
Q2 | $98K | Buy |
+401
| New | +$98.8K | ﹤0.01% | 5057 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5332 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5149 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5136 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5099 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5049 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5049 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5056 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5064 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5015 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5032 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4948 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4911 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4778 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4703 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4744 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4782 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4698 |
|
Other funds holding PHIO
SM
BlackRock's PHIO Position: Q3 2024 in Review
BlackRock held its Phio Pharmaceuticals (PHIO) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5294.
BlackRock first reported a position in PHIO in Q2 2021 and has held it in 4 quarters since. The position peaked at $98K in Q2 2021. 6 funds tracked by Wall St. Rank hold PHIO as of Q3 2024.
- BlackRock held 0 shares of Phio Pharmaceuticals worth $0 as of Q3 2024.
- BlackRock left its Phio Pharmaceuticals share count unchanged in Q3 2024.
- Phio Pharmaceuticals made up ﹤0.01% of BlackRock's portfolio in Q3 2024, its #5294 holding.
- BlackRock first reported a position in Phio Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
- BlackRock's Phio Pharmaceuticals position peaked at $98K in Q2 2021.
- 6 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2024.
Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.